摘要 |
<p>The present disclosure relates to, inter alia, antibodies, or antigen-binding fragments thereof, that bind to C5a and to use of the antibodies in methods for treating or preventing complement associated disorders such as, but not limited to, atypical hemolytic uremic syndrome, age related macular degeneration, rheumatoid arthritis, sepsis, severe burn, antiphospho lipid syndrome, asthma, lupus nephritis, Goodpasture's syndrome, and chronic obstructive pulmonary disease.</p> |
申请人 |
ALEXION PHARMACEUTICALS, INC. |
发明人 |
ROTHER, RUSSELL P.;SHERIDAN, DOUGLAS L.;TAMBURINI, PAUL P.;ZHANG, YUCHUN |